Form 8-K - Current report:
SEC Accession No. 0000950170-23-029395
Filing Date
2023-06-22
Accepted
2023-06-22 16:05:39
Documents
12
Period of Report
2023-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K hlvx-20230616.htm   iXBRL 8-K 52280
  Complete submission text file 0000950170-23-029395.txt   172858

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hlvx-20230616.xsd EX-101.SCH 2457
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hlvx-20230616_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hlvx-20230616_pre.xml EX-101.PRE 10222
6 EXTRACTED XBRL INSTANCE DOCUMENT hlvx-20230616_htm.xml XML 4880
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 231033360
SIC: 2836 Biological Products, (No Diagnostic Substances)